Filter Results:
(20)
Show Results For
- All HBS Web (20)
- Faculty Publications (2)
Show Results For
- All HBS Web (20)
- Faculty Publications (2)
Page 1 of 20
Results
- 06 Dec 2021
- News
Vision: Sound Science
It was a milestone to celebrate: Earlier this year, designations from FDA and European Union regulators moved researchers at the Boston-based startup Akouos, Inc., a step closer to producing the first-ever therapy for gene-mediated hearing loss. The product could... View Details
Keywords: Deb Blagg
- 01 Sep 2020
- News
Maintaining a Resilient Democracy
While many in this election year are focused on issues that divide the United States and the damage this discord may be doing to democracy, historian David Moss offers a perspective rooted in American democracy’s resilient past. “There have been many times when people... View Details
Keywords: Deb Blagg
- March 2015 (Revised February 2022)
- Supplement
CV Ingenuity (B): Epilogue
By: Regina E. Herzlinger and Andrew Otazo
Duke Rohlen used a lea-nfunding, iconoclastic strategy for his start up for a drug eluding balloon for peripheral artery disease. His giant competitors were first movers. Did Duke obtain the funding he sought? How did his DEB fare versus that of his competitors?
The... View Details
Keywords: CV Ingenuity; CVI; Drug Eluting Balloon; DEB; Drug Eluting Stent; Angioplasty Balloon; FoxHollow; Medical Device; Medical Device Startup; Premarket Approval; PMA; Lutonix; Stellarex; LEVANT; ILLUMENATE; Clinical Trials; Peripheral Arterial Disease; PAD; Healthcare Startups; Covidien; Health Care and Treatment; Health Testing and Trials; Business Startups; Commercialization; Strategy; Health Industry; Medical Devices and Supplies Industry; United States; Europe
Herzlinger, Regina E., and Andrew Otazo. "CV Ingenuity (B): Epilogue." Harvard Business School Supplement 315-087, March 2015. (Revised February 2022.)
- March 2015 (Revised January 2024)
- Case
CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies
By: Regina E. Herzlinger and Andrew Otazo
Duke Rohlen (HBS MBA ’01) hoped to win over a prominent venture capital investor for Series B financing of his firm CVI that was creating a drug-eluting balloon (DES) to treat peripheral arterial disease. As a second-mover, Duke felt he was more likely to acquire... View Details
Keywords: CV Ingenuity; CVI; Drug Eluting Balloon; DEB; Drug Eluting Stent; Angioplasty Balloon; FoxHollow; Medical Device; Medical Device Startup; Premarket Approval; PMA; Lutonix; Stellarex; LEVANT; ILLUMENATE; Clinical Trials; Peripheral Arterial Disease; PAD; Healthcare Startups; Covidien; Health Care and Treatment; Health Testing and Trials; Business Startups; Commercialization; Health Industry; Medical Devices and Supplies Industry; United States; Europe
Herzlinger, Regina E., and Andrew Otazo. "CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies." Harvard Business School Case 315-045, March 2015. (Revised January 2024.)
- Web
Podcast - Business & Environment
Week in May 2023. Moderated by HBS Prof. George Serafeim, the panel includes Carter Roberts, President & CEO of World Wildlife Fund, HBS professor Deb Spar, Bonita Stewart, Board Partner at Gradient Ventures, and Lauren Taylor Wolfe,... View Details
- Web
Partners - Case Method Project
Saratoga High School Saratoga, CA Subjects: Grade 12 AP U.S. Government, Grade 12 Standard Economics, Grade 11/12 Psychology elective CA 9 of 65 Deb Christenson Wildwood Middle-Upper School Los Angeles, CA CA 10 of 65 Rhonda Clements... View Details
- 01 Sep 2003
- News
Kumar Mahadeva
the Internet, one can collaborate with people halfway around the world throughout the entire business process,” he notes. “That’s one key area we’re focusing on for the future.” — DEB View Details
- Web
Teacher Profiles - Case Method Project
Newtonville, MA CA Deb Christenson Wildwood Middle-Upper School Los Angeles, CA MA Zach Christo Boston University Boston, MA WA Mary Anne Christy Lakeside High School Seattle, WA NC Sara Church John F. Kennedy High School Winston Salem,... View Details
- 01 Sep 2022
- What Do You Think?
Is It Time to Consider Lifting Tariffs on Chinese Imports?
feedback to last month’s column Does Religious Belief Affect Organizational Performance? We would like to think that religious belief does affect organizational performance. Deb Wiesner expressed this feeling in an email response to the... View Details
Keywords: Re: James L. Heskett
- 01 Sep 2003
- News
Jonathan Mariner
baseball’s future is fan-friendly. Mariner is part of a Commissioner’s task force charged with studying “how the next generation wants to be entertained and informed about the game.” With fans already taking advantage of Internet feeds to follow their favorite teams in... View Details
- 01 Sep 2003
- News
Christian Bjelland
to success. “Museums give people a sense of their roots,” he observes, “a chance to look back at their cultural heritage, which is especially important for a small country like ours. But they also give people wings to explore new aspects of their imagination. People... View Details
- Blog
Crossing the Bridge from Program Learning to Practical Application
When you attend an HBS Executive Education program, you never know what opportunities the experience may present. In fact, you could even find yourself becoming part of the teaching team. Ask Deb Barnes, Senior Managing Director of Fund... View Details
- 01 Sep 2003
- News
Jeanne Jackson
strengths. “During the go-go Internet years, there was pressure at Gap and Wal-Mart to treat the online operation as a separate business,” she recalls. “What we learned is that our e-commerce function needed to be an extension of what we were already doing well.”... View Details
- 01 Jun 1999
- News
New York Club Names Entrepreneur of the Year
with attendees than a simple awards dinner," said cochair Suzanna DeBaca (MBA '92). "Our next event will capitalize on this as well as provide additional opportunities for networking." Anyone wishing to nominate a company or inquire about a sponsorship should contact... View Details
- 01 Dec 1999
- News
Dan Fenn
When Bulletin editor Deb Blagg asked if I would do a short piece for this special 75th anniversary issue, I said yes immediately. Sounds fun and easy, I thought. I was right about the former and dead wrong about the latter. Where to... View Details
Keywords: Dan Fenn
- 02 Aug 2004
- Research & Ideas
Health Care Research and Prospects
come as a surprise to a lot of companies who are spending a lot of money and not getting a payoff for it. Q: There's been a lot of controversy around the ethics of stem cell research and cloning. Have you been keeping an eye on that? A: There's actually a major project... View Details
- 06 Jul 2009
- What Do You Think?
Are You Ready to Manage in an Irrational World?
new technology . Is (it) irrational (to) place a higher value on their current solution than they do on a future uncertain benefit(?)" What about the impact on management? Nicola Stevens concluded that "It (irrational behavior) makes suspect much of what we... View Details
Keywords: by Jim Heskett
- 10 Sep 2013
- First Look
First Look: September 10
of metrics to describe TV programs and broadcast advertising. Co-Founder and CEO Deb Roy said: "We want to measure audience engagement, not just media consumption." But what was the value of audience engagement? How could it be... View Details
Keywords: Sean Silverthorne
- 13 Oct 2003
- Research & Ideas
Negotiating Challenges for Women Leaders
are more flexible. You're only going to be enhancing all worker commitments. You're likely to be better at retaining talent, too. There's a nice example of what organizations can do from work by Maureen Scully and Deb Myerson. They... View Details
Keywords: by Martha Lagace